0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Biopharmaceutical Contract Manufacturing"

From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$2,990USDGBP
Biopharmaceuticals Contract Manufacturing Market Report 2025 - Product Thumbnail Image

Biopharmaceuticals Contract Manufacturing Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
From
EUR$3,500USDGBP
EUR$5,000USDGBP
From
EUR$3,750USDGBP
Biopharmaceuticals Contract Manufacturing Market - Product Thumbnail Image

Biopharmaceuticals Contract Manufacturing Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
EUR$4,150USDGBP
From
EUR$4,650USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Biopharmaceutical CMO and CRO Market Report 2025 - Product Thumbnail Image

Biopharmaceutical CMO and CRO Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Biopharmaceutical CMO Market Report 2025 - Product Thumbnail Image

Biopharmaceutical CMO Market Report 2025

  • Report
  • January 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
From
EUR$3,450USDGBP
From
EUR$4,499USDGBP
From
EUR$5,437USDGBP
From
EUR$6,000USDGBP
Loading Indicator

Biopharmaceutical Contract Manufacturing (CMO) is a service provided by specialized companies to biopharmaceutical companies. CMOs provide a range of services, from drug development and manufacturing to packaging and distribution. These services are tailored to the specific needs of the biopharmaceutical company, allowing them to focus on their core competencies. CMOs are able to provide a wide range of services, including process development, analytical testing, clinical trial materials, and commercial manufacturing. They also provide regulatory support, helping biopharmaceutical companies to navigate the complex regulatory landscape. CMOs are an important part of the biopharmaceutical industry, providing a cost-effective and efficient way to develop and manufacture drugs. Companies in the market include Lonza, Patheon, Boehringer Ingelheim, Catalent, and Ajinomoto Bio-Pharma Services. Show Less Read more